ADMINISTRATION OF ENGINEERED T CELLS FOR TREATMENT OF CANCERS IN THE CENTRAL NERVOUS SYSTEM

An improved method of treating cancers with engineered T cells is described. L'invention concerne une méthode améliorée de traitement de cancers avec des lymphocytes T génétiquement modifiés.

Saved in:
Bibliographic Details
Main Authors FORMAN, Stephen J, BADIE, Benham, PRICEMAN, Saul J, BROWN, Christine E
Format Patent
LanguageEnglish
French
Published 10.08.2017
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:An improved method of treating cancers with engineered T cells is described. L'invention concerne une méthode améliorée de traitement de cancers avec des lymphocytes T génétiquement modifiés.
Bibliography:Application Number: WO2017US16711